1. Home
  2. LSTA vs CALC Comparison

LSTA vs CALC Comparison

Compare LSTA & CALC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LSTA
  • CALC
  • Stock Information
  • Founded
  • LSTA 1980
  • CALC 2011
  • Country
  • LSTA United States
  • CALC United States
  • Employees
  • LSTA N/A
  • CALC N/A
  • Industry
  • LSTA Misc Health and Biotechnology Services
  • CALC Biotechnology: Pharmaceutical Preparations
  • Sector
  • LSTA Health Care
  • CALC Health Care
  • Exchange
  • LSTA Nasdaq
  • CALC Nasdaq
  • Market Cap
  • LSTA 31.2M
  • CALC 36.0M
  • IPO Year
  • LSTA N/A
  • CALC N/A
  • Fundamental
  • Price
  • LSTA $2.51
  • CALC $2.51
  • Analyst Decision
  • LSTA Strong Buy
  • CALC Strong Buy
  • Analyst Count
  • LSTA 1
  • CALC 5
  • Target Price
  • LSTA $15.00
  • CALC $18.20
  • AVG Volume (30 Days)
  • LSTA 58.9K
  • CALC 32.4K
  • Earning Date
  • LSTA 02-27-2025
  • CALC 03-27-2025
  • Dividend Yield
  • LSTA N/A
  • CALC N/A
  • EPS Growth
  • LSTA N/A
  • CALC N/A
  • EPS
  • LSTA N/A
  • CALC N/A
  • Revenue
  • LSTA N/A
  • CALC N/A
  • Revenue This Year
  • LSTA N/A
  • CALC N/A
  • Revenue Next Year
  • LSTA N/A
  • CALC N/A
  • P/E Ratio
  • LSTA N/A
  • CALC N/A
  • Revenue Growth
  • LSTA N/A
  • CALC N/A
  • 52 Week Low
  • LSTA $2.19
  • CALC $2.05
  • 52 Week High
  • LSTA $4.20
  • CALC $6.27
  • Technical
  • Relative Strength Index (RSI)
  • LSTA 40.33
  • CALC 39.62
  • Support Level
  • LSTA $2.51
  • CALC $2.37
  • Resistance Level
  • LSTA $2.66
  • CALC $2.75
  • Average True Range (ATR)
  • LSTA 0.19
  • CALC 0.22
  • MACD
  • LSTA -0.01
  • CALC 0.00
  • Stochastic Oscillator
  • LSTA 17.50
  • CALC 26.17

About LSTA Lisata Therapeutics Inc.

Lisata Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative therapies for the treatment of advanced solid tumors and other major diseases. Its product candidate, LSTA1, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively.

About CALC CalciMedica Inc.

CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapies for life-threatening inflammatory diseases with high unmet need. Its proprietary technology targets the inhibition of calcium release-activated calcium channels designed to modulate the immune response and protect against tissue cell injury, with the potential to provide therapeutic benefits in life-threatening inflammatory diseases for which there are no approved therapies.

Share on Social Networks: